Dopamine agonist treatment increases sensitivity to gamble outcomes in the hippocampus in de novo Parkinson's disease

Joyce P.M. van der Vegt, Oliver J. Hulme, Kristoffer H. Madsen, Carsten Buhmann, Bastiaan R. Bloem, Alexander Münchau, Rick C. Helmich, Hartwig R. Siebner*

*Corresponding author for this work

Fingerprint

Dive into the research topics of 'Dopamine agonist treatment increases sensitivity to gamble outcomes in the hippocampus in de novo Parkinson's disease'. Together they form a unique fingerprint.

Neuroscience